ADIPOQ and diabetes mellitus: We have also observed that, for patients without diabetes or those with diabetes not on treatment, the increments in adiponectin levels were negatively associated with changes in HOMA-IR at each time point over 36 months: likely contributing to the long-term improvement in diabetes control.